Global Live Poultry Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Live Poultry Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
A live poultry vaccine is a type of biological preparation used for preventing avian influenza outbreaks in chicken flocks. It contains attenuated strains of avian influenza virus and works by triggering immune responses against viral antigens present in sick birds without causing disease symptoms or death. Unlike conventional dead virus-based vaccines, live poultry vaccines require refrigerated storage and prompt administration after opening for best efficacy. Administered via drinking water or spray application methods, they typically provide protection lasting up to six months per dose depending on local environmental stressors and target pathogens. Their use represents one component in overall control strategies combatting the spread of bird flu among commercial poultry farms worldwide.
Global Live Poultry Vaccine market is projected to reach US$ 2224.3 million in 2029, increasing from US$ 1627 million in 2022, with the CAGR of 4.5% during the period of 2024 to 2029. Demand from Avian Encephalomyelitis and Chicken Anaemia are the major drivers for the industry.
The global live poultry vaccine market continues to experience robust growth due to factors such as increasing consumer preference for healthier meat products and increasing concerns about food safety. Additionally, there is a heightened awareness of animal welfare issues leading to increased pressure on producers to improve living conditions for animals raised for human consumption. Moreover, the COVID-19 crisis and its impact on supply chain disruptions, coupled with ongoing regulatory hurdles faced by large pharmaceutical firms entering into the space have opened new doors for smaller, agile companies to gain traction in this market. As a result, we anticipate continued growth of novel approaches towards vaccination delivery to ensure better biosecurity measures against pathogen risks in industrial settings.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Live Poultry Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Zoetis
Merck Animal Health
Boehringer Ingelheim
Elanco Animal Health
Phibro Animal Health
Virbac
Hipra
Venkys
Biovet
Ringpu Biology
Ceva Corporate
KM Biologics
Vaxxinova
Japfa Comfeed Indonesia
Nisseiken
Segment by Type
Injectable Vaccine
Spray Vaccine
Avian Encephalomyelitis
Chicken Anaemia
Egg Drop Syndrome
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Live Poultry Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Live Poultry Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Live Poultry Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Live Poultry Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Live Poultry Vaccine introduction, etc. Live Poultry Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Live Poultry Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Global Live Poultry Vaccine market is projected to reach US$ 2224.3 million in 2029, increasing from US$ 1627 million in 2022, with the CAGR of 4.5% during the period of 2024 to 2029. Demand from Avian Encephalomyelitis and Chicken Anaemia are the major drivers for the industry.
The global live poultry vaccine market continues to experience robust growth due to factors such as increasing consumer preference for healthier meat products and increasing concerns about food safety. Additionally, there is a heightened awareness of animal welfare issues leading to increased pressure on producers to improve living conditions for animals raised for human consumption. Moreover, the COVID-19 crisis and its impact on supply chain disruptions, coupled with ongoing regulatory hurdles faced by large pharmaceutical firms entering into the space have opened new doors for smaller, agile companies to gain traction in this market. As a result, we anticipate continued growth of novel approaches towards vaccination delivery to ensure better biosecurity measures against pathogen risks in industrial settings.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Live Poultry Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Zoetis
Merck Animal Health
Boehringer Ingelheim
Elanco Animal Health
Phibro Animal Health
Virbac
Hipra
Venkys
Biovet
Ringpu Biology
Ceva Corporate
KM Biologics
Vaxxinova
Japfa Comfeed Indonesia
Nisseiken
Segment by Type
Injectable Vaccine
Spray Vaccine
Segment by Application
Avian Encephalomyelitis
Chicken Anaemia
Egg Drop Syndrome
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Live Poultry Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Live Poultry Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Live Poultry Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Live Poultry Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Live Poultry Vaccine introduction, etc. Live Poultry Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Live Poultry Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices